跳至主要内容
临床试验/NCT02410785
NCT02410785已完成不适用

Efficacy of Polyglucosamine for Weight Loss - in a Randomized, Double-blind, Placebo-controlled Clinical Investigation

Certmedica International GmbH4 个研究点 分布在 2 个国家目标入组 115 人开始时间: 2009年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
115
试验地点
4
主要终点
Number of participants who could reduce their body weight by 5 or more per cent compared to the initial body weight.

研究概览

简要总结

The polyglucosamine, specification L112 is a medical device and in this clinical trial used for weight reduction of overweight and obese participants. The rationale for this study is to show that overweight can be reduced by taking 2 times daily 2 tablets with the main meals with the highest fat content.

详细描述

To have a comparable diet condition, all participants in both groups had to follow the recommendations of the German clinical practice guidelines on the management and prevention of obesity.

One group had to take the polyglucosamine tablets and the other group placebo tablets for at least 24 weeks. It is known, that polyglucosamine is a fat binder acting in a physical-chemical manner, the positive charged fiber is bound to the negative charged dietary fat and this complex in unable to pass the gut wall into the body but is naturally excreted, hence this energy is not available. Therefore, this medical device should show a measurable reduction in body weight.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
21 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • BMI > 26 and < 45
  • waist circumference of more than 88 cm for women and greater than 102 for men.

排除标准

  • pregnancy or breast-feeding, alcohol abuse, drug abuse or drug addiction, inability to fulfill the criteria of the trial protocol, cancer diseases, malignant tumors, pre-existence of chronic intestinal disease and known hypersensitivity reactions to crustaceans

结局指标

主要结局

Number of participants who could reduce their body weight by 5 or more per cent compared to the initial body weight.

时间窗: 24 weeks

次要结局

  • Reduction of waist circumference(24 weeks)
  • Change of body weight in kg(24 weeks)
  • Change of BMI(24 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

Efficacy of Polyglucosamine for Weight Loss | 临床试验